Published: Nov 02, 2026
Updated: Nov 02, 2026
.jpg)
An atrial septal defect (ASD) can affect people differently. For some, the opening between the heart's upper chambers causes few noticeable problems for years. For others, it may gradually strain the heart and lungs, making treatment a key consideration.
Although ASD closure can offer excellent outcomes, success depends on choosing the right approach for the specific defect. The opening's location and size, its effect on heart function, and the pressure in the blood vessels supplying the lungs help determine the best treatment and the results a patient can expect.
The 2025 ACC/AHA guidelines state that treatment decisions will be based on the defect's size and location, its effect on the heart, and pulmonary vascular pressure.
So how successful is ASD closure? That's going to vary according to the type of ASD, the procedure you've had and your overall cardiac and pulmonary status. That information helps patients and families understand what to expect during treatment and recovery.
An atrial septal defect is a hole (or the opening left after birth) in the atrial septum (the wall which separates the two upper chambers of the heart). It's a congenital heart defect.
This enables blood to flow between the chambers. In many cases, blood flows from the left atrium to the right atrium, increasing the volume of blood going to the lungs. A small ASD often causes no problems, whereas a larger defect makes the right side of the heart and the lungs work harder.
Some small defects will close up on their own, particularly in infancy. Larger defects will often require closure to reduce the chance of complications such as right heart enlargement, arrhythmias and pulmonary hypertension.
ASD closure is generally very successful when it fits the individual patient's anatomy and heart condition. No single success rate applies to all patients.
Many factors influence the outcome:
Atrial septal defect closure is successful in most appropriately selected patients. Outcomes depend on defect type, treatment method, and the patient's overall health.
Research comparing catheter-based closure with surgical repair also shows that catheter-based treatment is often associated with shorter length of stay and fewer complications in appropriate patients. Surgery remains an effective option, particularly for defects not suitable for device closure.
Remember, resolution does not mean there will be no subsequent complications or that you will have no current symptoms. The end result depends on the heart's condition before treatment and whether complications occur.
"One study looked at adults having surgery for secundum ASD, and again there were no deaths in the first 30 days. The one-year survival rate was 99.4%, and the five-year survival rate was 96.8%."
Your cardiologist can review it and explain how it applies to you and which treatment is most likely to give you a good long-term outcome.
ASDs are grouped according to the location and size of the septal defect. This grouping is important so that different treatments can be used to close the defect.
Secundum ASD refers to a defect that is found in the midportion of the atrial septum. This is by far the most common and may often be treated successfully by catheter-based closure, assuming that the defect and adjacent tissue are suitable for closure.
For the right patient, device closure avoids open-heart surgery and is associated with a shorter hospital stay and quicker recovery. Surgery may still be necessary if the defect is too large or if there isn't enough surrounding tissue to place the device.
A primum ASD occurs in the lower part of the atrial septum (close to the valves) and can be associated with abnormalities of the atrioventricular valves. Because of its position and the risk of associated valve disease, surgical repair is usually indicated. The outcome depends on the defect's nature, the valve's condition, and whether further surgery is required.
A sinus venosus ASD occurs where the major veins enter the heart and can be associated with abnormal pulmonary vein connections.
Surgery is the usual treatment, particularly if other associated abnormalities also need fixing. This depends on the individual's anatomy and the skill of the centre you're seeing. A research study on surgical repair of sinus venosus ASD found that the risk of death was very low. In 780 patients, in-hospital mortality was about 0.24%, and 30-day mortality was 0.5%.
A coronary sinus defect is a rare form of ASD (involving the septum between the coronary sinus and the left atrium). Management depends on the precise anatomy and any co-existing anomalies. Surgical repair is usually preferred, though management is individualised.
ASD doesn't have one single system that dictates treatment success. Severity is assessed by the amount of blood shunting through the defect, its effect on the heart, the patient's symptoms, and pulmonary artery pressure.
Rehabilitation is crucial for this procedure, the age of the patient, and whether or not the patient has additional heart-related disorders.
After either procedure, follow-up appointments are important. An echocardiogram and other tests can assess heart function, confirm closure, and look for residual flow or other complications.
Some patients notice improvements in breathlessness, fatigue, or exercise tolerance after successful closure. However, improvement may take time, and symptoms caused by other health conditions may not disappear. Abnormal heart rhythms can still occur (or may develop later on), especially in those who have their ASD closed in adulthood. Ongoing cardiac follow-up is still essential.
Closure of atrial septal defects achieves good results provided the right treatment is chosen for the patient's situation. Closure using catheters is effective for suitable ASDs, while open-heart surgery is useful for more complex defects, including many types of primum ASDs and sinus venosus ASDs.
The result depends on the size and location of the defect, its influence on the heart, pulmonary artery pressure, and the patient's health in general. Despite the encouraging results given by research in relation to catheter closure and surgery, the individual outcome may be different and successful closure might not mean that all the symptoms and complications are solved.
If you or your child suffer from ASD, consult a cardiologist specializing in congenital heart disease to find out if the closure is needed in your case and which method of closure is to be used.
Surgical recovery generally takes several weeks. Your care team will provide an individual recovery plan based on your procedure and progress. Recovery is usually quicker after catheter-based closure than after open-heart surgery. Many patients return to routine activities, though they may need to temporarily restrict strenuous activity.
The doctor will usually recommend an echocardiogram to assess the defect, blood flow, and the size and function of the heart chambers. Depending on your condition, you may also need a transoesophageal echocardiogram, an electrocardiogram (ECG), cardiac CT or MRI, or a cardiac catheterisation to measure pressures in the heart and lungs.
Most patients can slowly return to their usual activities after recovery, but the timing varies. Your doctor will advise when you can resume exercise, heavy lifting, work, or competitive sports based on your healing, heart function, and any remaining complications.
The most suitable treatment depends on the type, size, and location of your ASD, whether it is putting extra strain on your heart, and your pulmonary artery pressure. Your cardiologist may recommend imaging tests, such as an echocardiogram, to assess the defect. Your doctor will explain which option is safest and most effective for your condition.
No. Primum and sinus venosus ASDs are often going to need surgery for various reasons relating to their location or the presence of other abnormalities. The best approach will be determined by the imaging and the individual specialist assessment.

Pragun Gupta is a Doctor of Pharmacy (Pharm. D.) professional from Teerthanker Mahaveer University with hands-on experience in clinical pharmacology, clinical research, and evidence-based medical writing. Through her clinical and research exposure, she has developed a strong interest in pharmacoeconomics, pharmacology, therapeutics, and pharmacovigilance. As a medical writer, she works on medical and scientific research articles, patient education materials, and healthcare-focused content. Her clinical research and evidence-based writing experience enables her to translate complex medical information into clear, accurate, patient-friendly content while maintaining scientific credibility and medical accuracy. Her primary aim is to make healthcare information accessible and easy for patients and general readers to understand.

Dr. Naresh Kumar Goyal is highly trained as a cardiologist with exposure in virtually all aspects of cardiology. He qualified with an MD in internal medicine in 1999 from SMS Medical College, Jaipur, and served in the Cardiology Department as an honorary resident. From this stage, he also started with training in the temporary pacing of the pacemaker as well as interventional services.





Delhi, India

Istanbul, Turkey

Istanbul, Turkey

Istanbul, Turkey